azomycin has been researched along with antimony in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allaoui, A; François, C; Guilvard, E; Ouaissi, A; Zemzoumi, K | 1 |
| Koniordou, M; Patterson, S; Seifert, K; Wyllie, S | 1 |
| Braillard, S; Caljon, G; Chatelain, E; Hendrickx, S; Mabille, D; Maes, L; Mowbray, CE; Van den Kerkhof, M | 1 |
3 other study(ies) available for azomycin and antimony
| Article | Year |
|---|---|
Intracellular growth and metacyclogenesis defects in Trypanosoma cruzi carrying a targeted deletion of a Tc52 protein-encoding allele.
Topics: Alleles; Amino Acid Sequence; Animals; Antimony; Base Sequence; DNA, Protozoan; Gene Deletion; Macrophages; Metals, Heavy; Molecular Sequence Data; Nifurtimox; Nitroimidazoles; Oligonucleotides, Antisense; Phenotype; Protozoan Proteins; Transcription, Genetic; Trypanocidal Agents; Trypanosoma cruzi | 1999 |
Snapshot Profiling of the Antileishmanial Potency of Lead Compounds and Drug Candidates against Intracellular Leishmania donovani Amastigotes, with a Focus on Human-Derived Host Cells.
Topics: Animals; Antimony; Antiprotozoal Agents; Cell Differentiation; Cell Line; Host-Pathogen Interactions; Humans; Inhibitory Concentration 50; Leishmania donovani; Macrophages; Mice; Mice, Knockout; Monocytes; Nitroimidazoles; Primary Cell Culture; Stereoisomerism; Tetradecanoylphorbol Acetate | 2017 |
In vitro and in vivo pharmacodynamics of three novel antileishmanial lead series.
Topics: Animals; Antimony; Antiprotozoal Agents; Boron Compounds; Cricetinae; Female; Inhibitory Concentration 50; Leishmania donovani; Leishmania infantum; Leishmaniasis; Mice; Nitroimidazoles; Parasitic Sensitivity Tests; Pyrazoles | 2018 |